- Global Pharma News & Resources

Exclusive Interview with Alexander Stoll, Fresenius Kabi AB speaker at SMi’s Aseptic Processing Conference

SMi Group reports: Hear from industry expert Alexandar Stoll, Frensenius Kabi AB on the latest updates in the Aseptic Processing field ahead of the conference this September.

The inaugural Aseptic Processing conference will be convening on 20 and 21 September 2021 in London, UK. The industry is seeing crucial changes in regulation and guidance – fundamental documents and principles of implementation are in a pressing need to be dissected and discussed.

Interested parties can register at Register by 31 August 2021 to save £100. 

Ahead of the conference, SMi Group caught up with Alexandar Stoll, VP Competence Center Microbiology & Aseptic Technique, Fresenius Kabi AB with an exclusive speaker interview.

A teaser of what Alexander Stoll discussed about the current updates in the Aseptic Processing field in his exclusive interview:

The Aseptic Processing industry has matured significantly in previous years, what key developments have you witnessed in the last year within the field?
“There is definitely a trend to a higher degree of automation and less direct operator involvement in all parts of aseptic processing. Increased usage of barrier technologies and in particular isolators are another example of recent years key development.”

What are your thoughts on the developing regulatory environment in this field and how is this impacting your work at the moment? 
“When it comes to the revised Annex 1, which is currently the most apparent regulatory development, there is definitely an impact to work. Significantly increasing the Annex 1 document size, getting agreement with many stakeholders from different authorities and industry interest groups is a huge task. There are many different sterile product types and manufacturing technologies where the requirements need to be adapted to and where there needs to be technical solutions available for their implementation. In the end all want to achieve the best possible final Annex 1 document that is fit for its intended use and really benefits patients that in the end will receive the product.”

Alexander will be speaking at the conference on day-one on How to Prepare and be Ready for the Revised Annex 1 - A Pharmaceutical Company Perspective. 

To view full interview, download the brochure and to register, please visit: 

Sponsors: 3P innovation, Innerspace, ILC Dover and Exhibitor: STERIS 

For tailored sponsorship and branding packages contact Alia Malick, Director on +44 (0)20 7827 6168 or email  

For media enquiries, contact Simi Sapal, Head of Marketing on +44 (0)20 7827 6162 or email 

SMi’s Aseptic Processing Conference
London, UK (Virtual Attendance Option Available)
Conference: 20-21 September 2021
LinkedIn & Twitter: #SMiAseptic

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at  

Exclusive Interview with Alexander Stoll, Fresenius Kabi AB speaker at SMi’s Aseptic Processing Conference

Editor Details

Related Links

Last Updated: 05-Aug-2021